# A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

> **NCT00262210** · PHASE2 · COMPLETED · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 50 (—)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Cyclophosphamide Epirubicin Etoposide Prednisolone

## Key facts

- **NCT ID:** NCT00262210
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-06
- **Primary completion:** —
- **Final completion:** 1999-12
- **Target enrollment:** 50 (—)
- **Last updated:** 2005-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262210, "A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00262210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*